1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Chordoma Global Clinical Trials Review, H1, 2014

Chordoma Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • Global Data
  • -
  • 95 pages

Chordoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Chordoma Global Clinical Trials Review, H1, 2014" provides data on the Chordoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chordoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chordoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Chordoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Chordoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Chordoma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Chordoma 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Chordoma Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Sarcoma Alliance for Research through Collaboration 25
Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration 25
Novartis AG 26
Clinical Trial Overview of Novartis AG 26
Clinical Trial Overview of Top Institutes / Government 27
National Cancer Institute 27
Clinical Trial Overview of National Cancer Institute 27
Massachusetts General Hospital 28
Clinical Trial Overview of Massachusetts General Hospital 28
Children's Oncology Group 29
Clinical Trial Overview of Children's Oncology Group 29
St. John's Mercy Health Care 30
Clinical Trial Overview of St. John's Mercy Health Care 30
University of Heidelberg 31
Clinical Trial Overview of University of Heidelberg 31
Children's Cancer and Leukaemia Group 32
Clinical Trial Overview of Children's Cancer and Leukaemia Group 32
Istituto Nazionale per lo Studio e la Cura dei Tumori 33
Clinical Trial Overview of Istituto Nazionale per lo Studio e la Cura dei Tumori 33
Abramson Cancer Center 34
Clinical Trial Overview of Abramson Cancer Center 34
University of Virginia 35
Clinical Trial Overview of University of Virginia 35
University of Florida 36
Clinical Trial Overview of University of Florida 36
Five Key Clinical Profiles 37
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 95

List of Tables
Chordoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Chordoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Chordoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Chordoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Chordoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Chordoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Chordoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Chordoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Chordoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Chordoma Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Chordoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Chordoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Chordoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Chordoma Therapeutics, Global, Terminated Clinical Trials, 2014* 19
Chordoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Chordoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Chordoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Chordoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Chordoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2014* 25
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 26
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 27
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 28
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 29
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. John's Mercy Health Care, 2014* 30
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014* 31
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Cancer and Leukaemia Group, 2014* 32
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Nazionale per lo Studio e la Cura dei Tumori, 2014* 33
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2014* 34
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014* 35
Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014* 36

List of Figures
Chordoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Chordoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Chordoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Chordoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Chordoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Chordoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Chordoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Chordoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Chordoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Chordoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Chordoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Chordoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Chordoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Chordoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Chordoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Chordoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Chordoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.